Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Applications
ELISA
Western Blot
3D Cell Culture
PCR
Quantitative PCR
Digital PCR
Cell and Gene Therapy
In Vivo Models
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
Application Notes
Infographics
Events
Promotions
Multimedia
Biocompare Webinars
Technologies Transforming Precision Medicine
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
Register
Sign In
Biocompare
Products
Protein Biochemistry
Chemicals and Reagents
SB 334867, OX1 receptor antagonist
SB 334867, OX1 receptor antagonist from Abcam
Be the first to write a review!
Citations:
(3)
Supplier Page
Supplier Page from
Abcam for
SB 334867, OX1 receptor antagonist
Description
Selective OX
1
receptor antagonist
Product Specs
Company Info
Citations
Reviews
Product Specs
Item
SB 334867, OX1 receptor antagonist
Company
Abcam
Price
Supplier Page
View Company Product Page
Catalog Number
ab120164
Quantity
1 mg, 10 mg
Purity
0.99
Type
Activator/Agonist
Molecule Name
1-(2-Methylbenzo[d]oxazol-6-yl)-3-(1,5-naphthyridin-4-yl)urea
Add to Compare List
Abcam
Discovery Drive
Cambridge Biomedical Campus
Cambridge
CB2 0AX
United Kingdom
Phone
: +44 (0) 1223 696000 (option 1)
+44 (0) 1223 696000 (option 2)
+44 (0) 1223 771600
Company Profile
Website:
http://www.abcam.com
Citations (3)
(1)
Neuroprotective Effects of Transcranial Pulsed Current Stimulation: Modulation of Microglial Polarization in Traumatic Brain Injury
CNS Neuroscience & Therapeutics
September 7, 2025
Peng Yao, Bingkai Ren, Qianhui Zhou, Yang Bai, Zhen Feng
intraperitoneal injections
of BrdU (50 mg/kg) from 1 to 7 days post‐operation (dpo). The selective
OX1R
inhibitor
SB334867 (
ab120164
,
Abcam
) was dissolved in 5% DMSO and then diluted with 0.9% saline to a concentration of 10 mg/mL. The
(2)
Transcranial direct current stimulation promotes angiogenesis and improves neurological function via the OXA-TF-AKT/ERK signaling pathway in traumatic brain injury
Aging (Albany NY)
April 5, 2024
Bingkai Ren, Junwei Kang, Yan Wang, Xiangqiang Meng, Ying Huang, Yang Bai, Zhen Feng
twice daily. Simultaneously, we dissolved the selective orexin receptor 1 (OXR1)
inhibitor
SB334867 (
ab120164
,
Abcam
, USA) in a 5% DMSO solution, achieving a final concentration of 10 mg/ml. For the
tDCS
+SB334867
(3)
Low-intensity focused ultrasound attenuates early traumatic brain injury by OX-A/NF-κB/NLRP3 signaling pathway
Aging (Albany NY)
September 29, 2022
Lianghua Huang, Junwei Kang, Gengfa Chen, Wen Ye, Xiangqiang Meng, Qing Du, Zhen Feng
anesthesia. Intraperitoneal drug
injection
The anesthetized
rats
were injected intraperitoneally. SB334867 (
ab120164
,
Abcam
, USA), an orexin receptor 1 (OXR1) selective antagonist, was dissolved in 5% DMSO to the drug
<<
<
>
>>
Reviews
Be the First to Write a Review!
SB 334867, OX1 receptor antagonist from Abcam
Supplier Page
View Company Product Page
Product Specs
Company Info
Citations
Reviews
Back To Top